Please assess the completion status of the following clinical trial:

Trial Title: Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Prostate cancer~* Patient must have received primary definitive local therapy to the prostate (surgery and/or radiotherapy)~* Patient was surgically or pharmacologically castrated at least 6 months prior to starting the study~* Patient must have had a previous trial of anti-androgen therapy~* Patient must have a rising PSA~* No evidence of distant metastatic disease~* ECOG performance status \< 2~* Age \>18 years~* Patients must have normal hepatic function~Exclusion Criteria:~* Patients with a history of any previous cytotoxic therapy or radionuclide therapy (such as rhenium, strontium, or samarium)~* Patients may not be receiving any other investigational agents~* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements~* Patients receiving renal dialysis~* Patients with significant pulmonary disease who have received chronic or pulse steroid therapy within the last 3 months prior to randomization will be excluded~* Patients who have known hypersensitivity to any of the AndroGel ingredients, including testosterone that is chemically synthesized from soy

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Twenty subjects will receive testosterone gel
- B (Type: PLACEBO_COMPARATOR): Twenty subjects will receive the placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).